Sanoculis Ltd.

📍 Kiryat Ono, Israel🗓 Founded 2012👥 10 employees💰 Last funded Jul 2016
Medical Device🌐 sanoculis.com
Website LinkedIn
MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients’ through simplicity, low cost, fewer post-surgical complications and less hospitalization. • A novel Glaucoma treatment • Leaves nothing behind (stent-less) thus lowering the risk of complications • Can be easily combined with Cataract surgery • Medication-sparing which improves patients quality of life
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Sanoculis Ltd.?
Sanoculis Ltd. has 1 investors on record on gritt.io, 1 mid-stage.
When did Sanoculis Ltd. last raise funding?
The most recent investment in Sanoculis Ltd. recorded on gritt.io was in July 2016.
When was Sanoculis Ltd. founded?
Sanoculis Ltd. was founded in 2012.
What industry is Sanoculis Ltd. in?
Sanoculis Ltd. operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Sanoculis Ltd. based?
Sanoculis Ltd. is headquartered in Kiryat Ono, Israel.